Lyapunov exponents and phase diagrams reveal multi-factorial control over TRAIL-induced apoptosis

Molecular Systems Biology

Volumn 7, Issue , 2011, Pages

  Aldridge, Bree B ^a,b   Gaudet, Suzanne ^a   Lauffenburger, Douglas A ^a   Sorger, Peter K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

apoptosis; caspases; dynamical systems analysis; kinetic modeling; XIAP

Indexed keywords

CASPASE 3; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS; XIAP PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BEHAVIOR CHANGE; MUTATION; PHENOTYPE; PRIORITY JOURNAL; GENETICS; HUMAN; METABOLISM; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PHYSIOLOGY; TUMOR CELL LINE; UBIQUITINATION;

APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; HUMANS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; PHENOTYPE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UBIQUITINATION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 82155170633     PISSN: None     EISSN: 17444292     Source Type: Journal    
DOI: 10.1038/msb.2011.85     Document Type: Article

References (55)

1. Albeck JG, Burke JM, Aldridge BB, Zhang M, LauffenburgerDA, Sorger PK (2008a) Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol Cell 30: 11-25 (Pubitemid 351470145)
2. Albeck JG, Burke JM, Spencer SL, Lauffenburger DA, Sorger PK (2008b) Modeling a snap-action, variable-delay switch controlling extrinsic cell death. PLoS Biol 6: 2831-2852
3. Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK (2006a) Physicochemical modelling of cell signalling pathways. Nat Cell Biol 8: 1195-1203 (Pubitemid 44660581)
4. Aldridge BB, Haller G, Sorger PK, Lauffenburger DA (2006b) Direct Lyapunov exponent analysis enables parametric study of transient signalling governing cell behaviour. Syst Biol (Stevenage) 153: 425-432 (Pubitemid 44712258)
5. Algeciras-Schimnich A, Pietras EM, Barnhart BC, Legembre P, Vijayan S, Holbeck SL, Peter ME (2003) Two CD95 tumor classes with different sensitivities to antitumor drugs. Proc Natl Acad Sci USA 100: 11445-11450 (Pubitemid 37205955)
6. Barnhart BC, Alappat EC, Peter ME (2003) The CD95 type I/type II model. Sem Immunol 15: 185-193 (Pubitemid 38155825)
7. Bratton SB, Lewis J, Butterworth M, Duckett CS, Cohen GM (2002) XIAP inhibition of caspase-3 preserves its association with the Apaf-1 apoptosome and prevents CD95- and Bax-induced apoptosis. Cell Death Differ 9: 881-892 (Pubitemid 35023604)
8. Ceccarini C, Eagle H (1976) Some paradoxical effects of inhibitors of protein synthesis on protein turnover in cultured human cells. In Vitro 12: 346-351
9. Coulliette C, Lekien F, Paduan JD, Haller G, Marsden JE (2007) Optimal pollution mitigation in monterey bay based on coastal radar data and nonlinear dynamics. Environ Sci Technol 41: 6562-6572 (Pubitemid 47438001)
10. Cummins JM, Kohli M, Rago C, Kinzler KW, Vogelstein B, Bunz F (2004) X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res 64: 3006-3008 (Pubitemid 38581397)
11. Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388: 300-304 (Pubitemid 27317977)
12. Eckelman BP, Salvesen GS, Scott FL (2006) Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 7: 988-994 (Pubitemid 44480512)
13. Eissing T, Conzelmann H, Gilles ED, Allgower F, Bullinger E, Scheurich P (2004) Bistability analyses of a caspase activation model for receptor-induced apoptosis. J Biol Chem 279: 36892-36897 (Pubitemid 39129038)
14. Fisher RA (1918) The Correlation between relatives under the supposition of Mendelian inheritance. Trans R Soc Endinburgh 52: 399-433
15. Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, BlagosklonnyMV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, Cohen GM, De Laurenzi V, De Maria R, Deshmukh M, Dynlacht BD et al (2009) Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 16: 1093-1107
16. Gaudet S, Janes KA, Albeck JG, Pace EA, Lauffenburger DA, Sorger PK (2005) A compendium of signals and responses triggered by prodeath and prosurvival cytokines. Mol Cell Proteomics 4: 1569-1590 (Pubitemid 41555481)
17. Grell M, Krammer PH, Scheurich P (1994) Segregation of APO-1/Fas antigen- and tumor necrosis factor receptor-mediated apoptosis. Eur J Immunol 24: 2563-2566 (Pubitemid 24303108)
18. Harlin H, Reffey SB, Duckett CS, Lindsten T, Thompson CB (2001) Characterization of XIAP-deficient mice. Mol Cell Biol 21: 3604-3608 (Pubitemid 32381796)
19. Jaqaman K, Loerke D, Mettlen M, Kuwata H, Grinstein S, Schmid SL, Danuser G (2008) Robust single-particle tracking in live-cell timelapse sequences. Nat Methods 5: 695-702
20. Jost PJ, Grabow S, Gray D, McKenzie MD, Nachbur U, Huang DC, Bouillet P, Thomas HE, Borner C, Silke J, Strasser A, Kaufmann T (2009) XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 460: 1035-1039
21. Lavrik IN, Golks A, Riess D, Bentele M, Eils R, Krammer PH (2007) Analysis of CD95 threshold signaling: triggering of CD95 (FAS/ APO-1) at low concentrations primarily results in survival signaling. J Biol Chem 282: 13664-13671 (Pubitemid 47100557)
22. LeBlanc H, Lawrence D, Varfolomeev E, Totpal K, Morlan J, Schow P, Fong S, Schwall R, Sinicropi D, Ashkenazi A (2002) Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med 8: 274-281 (Pubitemid 34250106)
23. Lee KH, Feig C, Tchikov V, Schickel R, Hallas C, Schutze S, Peter ME, Chan AC (2006) The role of receptor internalization in CD95 signaling. EMBO J 25: 1009-1023 (Pubitemid 43372115)
24. Lestas I, Vinnicombe G, Paulsson J (2010) Fundamental limits on the suppression of molecular fluctuations. Nature 467: 174-178
25. Letai AG (2008) Diagnosing and exploiting cancers addiction to blocks in apoptosis. Nat Rev Cancer 8: 121-132 (Pubitemid 351161322)
26. Lovric MM, Hawkins CJ (2010) TRAIL treatment provokes mutations in surviving cells. Oncogene 29: 5048-5060
27. Maas C, Verbrugge I, de Vries E, Savich G, van de Kooij LW, Tait SW, Borst J (2010) Smac/DIABLO release from mitochondria and XIAP inhibition are essential to limit clonogenicity of Type I tumor cells after TRAIL receptor stimulation. Cell Death Differ 17: 1613-1623
28. MacFarlane M, MerrisonW, Bratton SB, CohenGM(2002) Proteasomemediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J Biol Chem 277: 36611-36616
29. Newsom-Davis T, Prieske S, Walczak H (2009) Is TRAIL the holy grail of cancer therapy? Apoptosis 14: 607-623
30. Oberst A, Pop C, Tremblay AG, Blais V, Denault JB, Salvesen GS, Green DR (2010) Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation. J Biol Chem 285: 16632-16642
31. Ozoren N, El-Deiry WS (2002) Defining characteristics of types I and II apoptotic cells in response to TRAIL. Neoplasia 4: 551-557 (Pubitemid 35417080)
32. Rateitschak K, Wolkenhauer O (2010) Thresholds in transient dynamics of signal transduction pathways. J Theor Biol 264: 334-346
33. Rehm M, Huber HJ, Dussmann H, Prehn JH (2006) Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. EMBO J 25: 4338-4349 (Pubitemid 44435231)
34. Rehm M, Huber HJ, Hellwig CT, Anguissola S, Dussmann H, Prehn JH (2009) Dynamics of outer mitochondrial membrane permeabilization during apoptosis. Cell Death Differ 16: 613-623
35. Ricci JE, Munoz-Pinedo C, Fitzgerald P, Bailly-Maitre B, Perkins GA, Yadava N, Scheffler IE, Ellisman MH, Green DR (2004) Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 117: 773-786 (Pubitemid 38748893)
36. Riedl SJ, Shi Y (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5: 897-907 (Pubitemid 39486541)
37. Rudner J, Jendrossek V, Lauber K, Daniel PT, Wesselborg S, Belka C (2005) Type I and type II reactions in TRAIL-induced apoptosis- results from dose-response studies. Oncogene 24: 130-140 (Pubitemid 40143872)
38. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675-1687 (Pubitemid 28119121)
39. Scaffidi C, Schmitz I, Krammer PH, Peter ME (1999a) The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274: 1541-1548
40. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, Peter ME (1999b) Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 274: 22532-22538
41. Schile AJ, Garcia-Fernandez M, Steller H (2008) Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes Dev 22: 2256-2266
42. Schmitz I, Walczak H, Krammer PH, Peter ME (1999) Differences between CD95 type I and II cells detected with the CD95 ligand. Cell Death Differ 6: 821-822 (Pubitemid 29488078)
43. Shawgo ME, Shelton SN, Robertson JD (2009) Caspase-9 activation by the apoptosome is not required for fas-mediated apoptosis in type II Jurkat cells. J Biol Chem 284: 33447-33455
44. Siegel RM, Muppidi JR, Sarker M, Lobito A, Jen M, Martin D, Straus SE, Lenardo MJ (2004) SPOTS: signaling protein oligomeric transduction structures are early mediators of death receptorinduced apoptosis at the plasma membrane. J Cell Biol 167: 735-744 (Pubitemid 39565153)
45. Silke J, Kratina T, Chu D, Ekert PG, Day CL, Pakusch M, Huang DC, Vaux DL (2005) Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance. Proc Natl Acad Sci USA 102: 16182-16187 (Pubitemid 41688888)
46. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK (2009) Nongenetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 459: 428-433
47. Sun XM, Bratton SB, Butterworth M, MacFarlane M, Cohen GM (2002) Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J Biol Chem 277: 11345-11351 (Pubitemid 34952900)
48. Suzuki Y, Nakabayashi Y, Nakata K, Reed JC, Takahashi R (2001) Xlinked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and - 7 in distinct modes. J Biol Chem 276: 27058-27063
49. Tyas L, Brophy VA, Pope A, Rivett AJ, Tavare JM (2000) Rapid caspase- 3 activation during apoptosis revealed using fluorescenceresonance energy transfer. EMBO Rep 1: 266-270
50. Vaughan AT, Betti CJ, Villalobos MJ (2002) Surviving apoptosis. Apoptosis 7: 173-177 (Pubitemid 34273133)
51. Vaughan AT, Betti CJ, Villalobos MJ, Premkumar K, Cline E, Jiang Q, Diaz MO (2005) Surviving apoptosis: a possible mechanism of benzene-induced leukemia. Chem Biol Interact 153-154: 179-185 (Pubitemid 40797809)
52. Wilson TR, McEwan M, McLaughlin K, Le Clorennec C, Allen WL, Fennell DA, Johnston PG, Longley DB (2009) Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in type II colorectal cancer cells. Oncogene 28: 63-72
53. Wurstle ML, Laussmann M.A., Rehm M (2010) The caspase-8 dimerization/dissociation balance is a highly potent regulator of caspase-8, -3, -6 signaling. J Biol Chem 285: 33209-33218
54. Yang Y, Fang S, Jensen JP,Weissman A.M., Ashwell JD (2000) Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288: 874-877 (Pubitemid 30257739)
55. Yule GU (1906) On the theory of inheritance of quantitative compound characters on the basis of Mendels laws-a preliminary note. In Third International Conference on Genetics, pp 140-142